| Epidemiology of hepatitis B and C viruses: a global overview HS Te, DM Jensen Clinics in liver disease 14 (1), 1-21, 2010 | 680 | 2010 |
| An interferon-free antiviral regimen for HCV after liver transplantation PY Kwo, PS Mantry, E Coakley, HS Te, HE Vargas, R Brown Jr, F Gordon, ... New England Journal of Medicine 371 (25), 2375-2382, 2014 | 481 | 2014 |
| Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States MH Le, P Devaki, NB Ha, DW Jun, HS Te, RC Cheung, MH Nguyen PloS one 12 (3), e0173499, 2017 | 311 | 2017 |
| Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events LB VanWagner, M Bhave, HS Te, J Feinglass, L Alvarez, ME Rinella Hepatology 56 (5), 1741-1750, 2012 | 247 | 2012 |
| Mechanism of action of ribavirin in the treatment of chronic hepatitis C HS Te, G Randall, DM Jensen Gastroenterology & hepatology 3 (3), 218, 2007 | 208 | 2007 |
| Autoimmune hepatitis associated with the use of black cohosh: a case study SM Cohen, AM O’Connor, J Hart, NH Merel, HS Te Menopause 11 (5), 575-577, 2004 | 134 | 2004 |
| Operative risk of total hip and knee arthroplasty in cirrhotic patients SM Cohen, HS Te, J Levitsky The Journal of arthroplasty 20 (4), 460-466, 2005 | 106 | 2005 |
| Serum phosphorus levels predict clinical outcome in fulminant hepatic failure PY Chung, MD Sitrin, HS Te Liver Transplantation 9 (3), 248-253, 2003 | 106 | 2003 |
| Liver transplantation in the obese cirrhotic patient EK Spengler, JG O’Leary, HS Te, S Rogal, AA Pillai, A Al-Osaimi, A Desai, ... Transplantation 101 (10), 2288-2296, 2017 | 93 | 2017 |
| Current state of combined heart–liver transplantation in the United States HS Te, AS Anderson, JM Millis, V Jeevanandam, DM Jensen The Journal of heart and lung transplantation 27 (7), 753-759, 2008 | 91 | 2008 |
| Entecavir safety and effectiveness in a national cohort of treatment‐naïve chronic hepatitis B patients in the US–the ENUMERATE study J Ahn, HM Lee, JK Lim, CQ Pan, MH Nguyen, W Ray Kim, A Mannalithara, ... Alimentary pharmacology & therapeutics 43 (1), 134-144, 2016 | 86 | 2016 |
| Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice H Te, K Doucette Clinical Transplantation 33 (9), e13514, 2019 | 76 | 2019 |
| Rifaximin decreases the incidence and severity of acute kidney injury and hepatorenal syndrome in cirrhosis T Dong, A Aronsohn, K Gautham Reddy, HS Te Digestive diseases and sciences 61, 3621-3626, 2016 | 70 | 2016 |
| Liver transplantation for alcoholic hepatitis in the United States: excellent outcomes with profound temporal and geographic variation in frequency TG Cotter, B Sandıkçı, S Paul, A Gampa, J Wang, H Te, A Pillai, KG Reddy, ... American Journal of Transplantation 21 (3), 1039-1055, 2021 | 67 | 2021 |
| Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of … J Nelson, N Alvey, L Bowman, J Schulte, MC Segovia, J McDermott, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42 (8 …, 2022 | 66 | 2022 |
| The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation J Levitsky, J Hart, SM Cohen, HS Te Liver transplantation 9 (7), 733-736, 2003 | 66 | 2003 |
| Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients RM Kwok, J Ahn, TD Schiano, HS Te, DR Potosky, A Tierney, R Satoskar, ... Liver Transplantation 22 (11), 1536-1543, 2016 | 63 | 2016 |
| Screening for zinc deficiency in patients with cirrhosis: when should we start? S Sengupta, K Wroblewski, A Aronsohn, N Reau, KG Reddy, D Jensen, ... Digestive diseases and sciences 60, 3130-3135, 2015 | 62 | 2015 |
| Peginterferon α-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon α-2b plus ribavirin … SK Herrine, RS Brown, DE Bernstein, MS Ondovik, E Lentz, H Te Digestive diseases and sciences 50, 719-726, 2005 | 56 | 2005 |
| Gastrointestinal manifestations of autosomal-dominant polycystic kidney disease AE Mikolajczyk, HS Te, AB Chapman Clinical Gastroenterology and Hepatology 15 (1), 17-24, 2017 | 55 | 2017 |
